This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acrophobia Questionnaire (AQ)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Behavioral Approach Task (BAT)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Heights Interpretation Questionnaire (HIQ)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Acrophobia Questionnaire (AQ)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)
Behavioral Approach Task (BAT)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)
Heights Interpretation Questionnaire (HIQ)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)